Page 6 - Pfizer

South Korea authorises Novavax Covid-19 vaccine, imports Pfizer pills

At least 21,000 of Pfizer's antiviral pills, called Paxlovid, will arrive in South Korea on Thursday, with another 10,000 more expected to arrive by the end of the month, the health ministry said

Pfizer's Omicron specific vaccine to be ready by March, says CEO

Pfizer's vaccine that specifically targets the Omicron variant of Covid-19 will be ready in March, the pharmaceutical giant's CEO Albert Bourla has said

Omicron spread: Pfizer seeks conditional EU authorisation for Covid-19 pill

The announcement comes as countries in much of the 27-nation bloc are reporting soaring numbers of infections

US CDC recommends Pfizer's Covid vaccine booster dose for ages 12 to 15

The US's CDC said it expanded the eligibility of Pfizer Inc and BioNTech SE's booster doses to those 12 to 15 years old

BioNTech, Pfizer plan shingles shot in third joint mRNA project

The partners expect to start human trials of the new vaccine in the second half of this year, they said in a statement

Covid-19: US to double order of Pfizer treatment courses, says Biden

To decrease hospitalisations and deaths from Covid, the US administration is going to double its order of Pfizer treatment courses, President Joe Biden said

US FDA authorises Pfizer-BioNTech booster shots for kids aged 12-15

The US FDA has expanded the emergency use authorisation for the Pfizer-BioNTech Covid-19 vaccine boosters to children aged 12 to 15.

Covid: FDA expands Pfizer boosters for more teens as omicron surges

The US is expanding Covid-19 boosters as it confronts the omicron surge, with the Food and Drug Administration allowing extra Pfizer shots for children as young as 12.

Why are mRNA vaccines effective against severe coronavirus infection?

A team of US researchers has explored the success behind the new mRNA vaccine technology used by Pfizer and Moderna to make vaccines against Covid.

South Korea approves emergency authorisation of Pfizer's oral Covid pill

South Korea on Monday approved an emergency authorization of US drug giant Pfizer Inc.'s oral drug to treat Covid-19, making it the first such pill to be used in the country.

US donates 5 million doses of Pfizer coronavirus vaccine to Pakistan

The United States has announced shipping an additional five million doses of Pfizer's coronavirus vaccine to Pakistan through the COVAX facility.

United States donates 664,560 doses of Pfizer vaccines to Nepal

The United States has donated 664,560 new doses of Pfizer vaccine to Nepal to help it intensify its fight against the coronavirus, the US Embassy said here on Friday. The new doses of Pfizer vaccine given to Nepal free of cost is in addition to the doses the US had provided early this year when the cases of coronavirus were constantly on a rise. "The US government has donated an additional 664,560 doses of Pfizer vaccine to Nepal government to fight COVID-19. These highly effective life-saving vaccines for ages 12 and older add to the 100,620 doses of Pfizer vaccines and 1.535 million single-dose Johnson & Johnson vaccines the United States gifted to Nepal earlier this year," the US Embassy in Kathmandu said in a statement. This support augments the more than USD 122 million in assistance provided (excluding including vaccine costs) to Nepal to-date in the form of life-saving medical supplies, training, and technical support, the statement added. The US said it is donating ...

Pfizer's Covid pill will take about 6-8 months to come to US markets

While the US FDA has approved Pfizer antiviral pill to treat Covid-19, the White House has warned that the drug will not be available in the markets before six-eight months.

US FDA authorizes Pfizer's Covid-19 antiviral pill for people aged 12

The US Food and Drug Administration (FDA) on Wednesday (local time) authorized Pfizer's Paxlovid COVID-19 pill for high-risk people aged 12 and over to treat coronavirus disease (COVID-19)."The US Food and Drug Administration issued an emergency use authorization (EUA) for Pfizer's Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults and pediatric patients (12 years of age and older weighing at least 40 kilograms or about 88 pounds) with positive results of direct SARS-CoV-2 testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death," US Food and Drug said in a statement."Today's authorization introduces the first treatment for COVID-19 that is in the form of a pill that is taken orally -- a major step forward in the fight against this global pandemic," said Patrizia Cavazzoni, M.D., director of the FDA's Center for Drug Evaluation and

UK to offer Pfizer's Covid-19 vaccine shots to at-risk children aged 5-11

The UK Health Security Agency allowed the use of smaller doses of Pfizer's Covid-19 vaccines in children aged 5 to 11 who are at a higher risk from the virus

Pfizer pill becomes 1st US-authorised home Covid-19 treatment

The drug, Paxlovid, is a faster, cheaper way to treat early Covid-19 infections

LIVE: 8 more Omicron cases in Maharashtra, 6 in Karnataka, 4 in Kerala

Of the six cases in Karnataka, one is a passenger from the UK, while five others have been detected from Covid clusters that have emerged from two educational institutions in Dakshina Kannada district

Pfizer Inc says coronavirus pandemic could extend to 2024

Vaccine data for younger children delayed, says Pfizer

Pfizer study tests extra Covid-19 vaccine dose for kids under 5

For children younger than 5, Pfizer is testing an even smaller dose, just 3 micrograms or a tenth of the adult dose

CDC panel recommends Pfizer, Moderna Covid vaccines over J&J shot

Most Americans should be given the Pfizer or Moderna vaccines instead of the Johnson & Johnson shot that can cause rare but serious blood clots, U.S. health advisers recommended Thursday. The strange clotting problem has caused nine confirmed deaths after J&J vaccinations while the Pfizer and Moderna vaccines don't come with that risk and also appear to be more effective, advisers to the Centers for Disease Control and Prevention said. It's an unusual move and the CDC's director, Dr. Rochelle Walensky, must decide whether to accept the panel's advice. Until now the U.S. has treated all three COVID-19 vaccines available to Americans as an equal choice, since large studies found they all offered strong protection and early supplies were limited. J&J's vaccine initially was welcomed as a single-dose option that could be especially important for hard-to-reach groups like homeless people who might not get the needed second dose of the Pfizer or Moderna options. But the CDC's ..